Provided by Tiger Trade Technology Pte. Ltd.

Vyome Holdings, Inc.

2.18
+0.01000.46%
Pre-market: 2.220.0398+1.83%08:11 EDT
Volume:4K
Turnover:9.53K
Market Cap:15.30M
PE:-1.35
High:2.18
Open:2.13
Low:2.13
Close:2.17
52wk High:9.56
52wk Low:1.75
Shares:7.02M
Float Shares:1.54M
Volume Ratio:0.75
T/O Rate:0.29%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.6111
EPS(LYR):-4.7480
ROE:-999.17%
ROA:-48.79%
PB:2.53
PE(LYR):-0.46

Loading ...

Vyome Holdings Price Target Announced at $3.50/Share by Chardan Capital

Dow Jones
·
34 mins ago

Chardan Initiates Vyome Holdings at Buy With $3.50 Price Target

MT Newswires Live
·
1 hour ago

Vyome initiated with a Buy at Chardan

TIPRANKS
·
3 hours ago

Vyome Holdings CFO Jerry Leonard Files Initial Beneficial Ownership Statement

Reuters
·
Yesterday

Vyome names Jerry Leonard as CFO

TIPRANKS
·
Aug 29

Vyome - Appoints Jerry Leonard as CFO on August 27, 2026 - SEC Filing

THOMSON REUTERS
·
Aug 29

Vyome Holdings Appoints Jerry Leonard as CFO Effective Sept. 1

Reuters
·
Aug 29

Sweden's Modus Therapeutics Narrows Q2 Net Loss, Extends Financing

Reuters
·
Aug 26

Biopharma Firm Vyome Holdings Posts Q2 Net Loss

Reuters
·
Aug 25

Vyome Holdings Inc Q2 EPS USD 0.1

THOMSON REUTERS
·
Aug 25

Vyome Q2 FY26 Net Loss Narrows to $720,000; Operating Expenses Rise to $874,000

Reuters
·
Aug 25

Vyome Holdings Reports Second Quarter 2026 Results Highlighted by Advancement of Lead Vt-1953 Program, Pipeline Expansion and Strong Balance Sheet

THOMSON REUTERS
·
Aug 25

Press Release: Vyome Holdings Reports Second Quarter 2026 Results Highlighted by Advancement of Lead VT-1953 Program, Pipeline Expansion and Strong Balance Sheet

Dow Jones
·
Aug 25

Vyome Holdings Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 13

Vyome Net Loss Widens to $719,683 in Q2 FY26; Revenue Falls to $26,955

Reuters
·
Aug 13

Vyome Holdings Inc Expected to Post a Loss of 19 Cents a Share - Earnings Preview

Reuters
·
Aug 11

Vyome announces CNIPA granted patent covering formula related to besifloxacin

TIPRANKS
·
Jul 01

Vyome Wins China Patent for Besifloxacin Gel in Inflammatory Acne

Reuters
·
Jul 01

Vyome Granted Chinese Patent Strengthening Immuno-inflammation Portfolio

THOMSON REUTERS
·
Jul 01

Vyome net loss widens to $985,521 in Q1 FY26

Reuters
·
May 28